IL150366A0 - 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives - Google Patents

4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives

Info

Publication number
IL150366A0
IL150366A0 IL15036600A IL15036600A IL150366A0 IL 150366 A0 IL150366 A0 IL 150366A0 IL 15036600 A IL15036600 A IL 15036600A IL 15036600 A IL15036600 A IL 15036600A IL 150366 A0 IL150366 A0 IL 150366A0
Authority
IL
Israel
Prior art keywords
piperazinyl
piperidinyl
phenyl
tetrahydropyridyl
derivatives
Prior art date
Application number
IL15036600A
Other languages
English (en)
Original Assignee
Lundbeck & Co As H
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lundbeck & Co As H filed Critical Lundbeck & Co As H
Publication of IL150366A0 publication Critical patent/IL150366A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/20Oxygen atoms
    • C07D215/22Oxygen atoms attached in position 2 or 4
    • C07D215/227Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/20Hypnotics; Sedatives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D217/00Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/073Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Indole Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL15036600A 1999-12-30 2000-12-22 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives IL150366A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA199901887 1999-12-30
PCT/DK2000/000728 WO2001049679A1 (en) 1999-12-30 2000-12-22 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives

Publications (1)

Publication Number Publication Date
IL150366A0 true IL150366A0 (en) 2002-12-01

Family

ID=8108820

Family Applications (3)

Application Number Title Priority Date Filing Date
IL15036600A IL150366A0 (en) 1999-12-30 2000-12-22 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives
IL150366A IL150366A (en) 1999-12-30 2002-06-23 History 4-Panyl-1-Piprazinyl, Piprazinyl, -Pipridinyl and tetrahydropyridyl
IL186954A IL186954A0 (en) 1999-12-30 2007-10-25 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
IL150366A IL150366A (en) 1999-12-30 2002-06-23 History 4-Panyl-1-Piprazinyl, Piprazinyl, -Pipridinyl and tetrahydropyridyl
IL186954A IL186954A0 (en) 1999-12-30 2007-10-25 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives

Country Status (32)

Country Link
US (2) US7074796B2 (ko)
EP (2) EP1246817B1 (ko)
JP (1) JP2003519225A (ko)
KR (2) KR100792186B1 (ko)
CN (2) CN1244577C (ko)
AR (1) AR029461A1 (ko)
AT (2) ATE395333T1 (ko)
AU (2) AU783786B2 (ko)
BG (1) BG106960A (ko)
BR (1) BR0016953A (ko)
CA (1) CA2395869C (ko)
CZ (1) CZ20022603A3 (ko)
DE (2) DE60038911D1 (ko)
DK (2) DK1246817T3 (ko)
EA (2) EA008627B1 (ko)
ES (2) ES2223628T3 (ko)
HK (1) HK1055960A1 (ko)
HR (1) HRP20020567A2 (ko)
HU (1) HUP0203839A3 (ko)
IL (3) IL150366A0 (ko)
IS (1) IS6432A (ko)
MX (1) MXPA02006590A (ko)
NO (2) NO323401B1 (ko)
NZ (2) NZ519740A (ko)
PL (1) PL355502A1 (ko)
PT (2) PT1464641E (ko)
SG (1) SG152900A1 (ko)
SK (1) SK11072002A3 (ko)
TR (2) TR200201690T2 (ko)
UA (1) UA73756C2 (ko)
WO (1) WO2001049679A1 (ko)
ZA (1) ZA200205019B (ko)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030087917A1 (en) * 2000-03-27 2003-05-08 Dorothea Strack Use of dopamine-d3 receptor ligands for the treatment of diseases of the central nervous system
GB0117577D0 (en) * 2001-02-16 2001-09-12 Aventis Pharm Prod Inc Novel heterocyclic substituted carbonyl derivatives and their use as dopamine D receptor ligands
FR2831166B1 (fr) 2001-10-18 2004-02-27 Sanofi Synthelabo Aralkyl-tetrahydro-pyridines, leur preparation et compositions pharmaceutiques les contenant
BR0215430A (pt) 2001-12-28 2004-12-14 Acadia Pharm Inc Composto e seus usos, composição, método de tratamento, método de aumento d atividade de um receptor colinérgico, método de tratamento e prevenção ou redução dos sintomas associados à disfunção em mamìferos
US7550459B2 (en) 2001-12-28 2009-06-23 Acadia Pharmaceuticals, Inc. Tetrahydroquinoline analogues as muscarinic agonists
AU2004303461B2 (en) * 2003-12-23 2011-04-28 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-benzyl amine derivatives as SSRI
DE102004027358A1 (de) * 2004-06-04 2005-12-29 Abbott Gmbh & Co. Kg Pyrimidinverbindungen und ihre Verwendung
AR052308A1 (es) 2004-07-16 2007-03-14 Lundbeck & Co As H Derivados de 2-(1h-indolilsulfanil)-arilamina y una composicion farmaceutica que contiene al compuesto
FR2878524B1 (fr) * 2004-12-01 2007-01-19 Bioprojet Soc Civ Ile Nouveaux derives d'arylpiperazine
AR054393A1 (es) 2005-06-17 2007-06-20 Lundbeck & Co As H Derivados de benzo(b)furano y benzo(b)tiofeno, composiciones farmaceuticas que los contienen y su uso en la fabricacion de un medicamento para el tratamiento de enfermedades mediadas por la inhibicion de la reabsorcion de neurotransmisores de amina biogenicos.
US7629473B2 (en) 2005-06-17 2009-12-08 H. Lundbeck A/S 2-(1H-indolylsulfanyl)-aryl amine derivatives
EP1870405A1 (en) * 2006-06-22 2007-12-26 Bioprojet Carbonylated (Aza)cyclohexanes as dopamine D3 receptor ligands
CN104337812B (zh) 2013-07-29 2018-09-14 广东东阳光药业有限公司 取代的杂芳基化合物及其使用方法和用途
US9714232B2 (en) 2013-12-20 2017-07-25 Sunshine Lake Pharma Co., Ltd. Substituted piperazine compounds and methods of use thereof
CN106243088B (zh) 2015-06-03 2019-01-04 广东东阳光药业有限公司 取代的哌嗪化合物及其使用方法和用途

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB944443A (ko) * 1959-09-25 1900-01-01
US3468882A (en) * 1966-10-07 1969-09-23 Sterling Drug Inc Phenylhydrazone derivatives as intermediates for preparing indoles
DE2138865A1 (de) * 1970-08-15 1973-02-22 Sumitomo Chemical Co 3-indolylpiperazine, verfahren zu ihrer herstellung und arzneimittel
FR2635104B1 (fr) * 1988-08-03 1992-04-30 Synthelabo Derives d'indolone, leur preparation et leur application en therapeutique
US4950664A (en) * 1988-09-16 1990-08-21 Rugby-Darby Group Companies, Inc. Nasal administration of benzodiazepine hypnotics
DE4101686A1 (de) * 1991-01-22 1992-07-23 Merck Patent Gmbh Indolderivate
US5556857A (en) * 1991-05-08 1996-09-17 Otsuka Pharmaceutical Co., Ltd. Disturbance-of-consciousness improving agent
IT1255178B (it) * 1992-06-26 1995-10-20 Pierrel Spa N(eter0)-aril-n(etero)-tetralinalchil piperazine aventi attivita' serotoninergica,dopaminergica e adrenergica
AU6435594A (en) * 1993-04-15 1994-11-08 Merck Sharp & Dohme Limited Indole derivatives as dopamine d4 antagonists
ES2273764T3 (es) * 1993-06-28 2007-05-16 Wyeth Nuevos tratamientos que utilizan derivados de fenetilamina.
DE59509727D1 (de) * 1994-12-07 2001-11-22 Byk Gulden Lomberg Chem Fab Uracilderivate
WO1998008816A1 (fr) * 1996-08-26 1998-03-05 Meiji Seika Kaisha, Ltd. Derives d'indoxyle et psychotropes
BR9811557A (pt) * 1997-08-15 2000-08-22 Pfizer Prod Inc Derivados do 2-)4-aril ou heteroaril-piperazin-1-ilmetil)-1h-indol
US6355644B1 (en) * 1999-06-14 2002-03-12 Neurogen Corporation Benzylpiperazinyl-indolinylethanones
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
TW580446B (en) * 2003-05-15 2004-03-21 Benq Corp Color electrode array printer

Also Published As

Publication number Publication date
BR0016953A (pt) 2003-02-25
CN1803784A (zh) 2006-07-19
EA200400641A1 (ru) 2004-10-28
HUP0203839A3 (en) 2004-07-28
HRP20020567A2 (en) 2005-04-30
EP1246817B1 (en) 2004-06-23
AU783786B2 (en) 2005-12-08
HUP0203839A2 (hu) 2003-02-28
AU2006201000A1 (en) 2006-04-06
CN1244577C (zh) 2006-03-08
HK1055960A1 (en) 2004-01-30
BG106960A (bg) 2003-04-30
NZ519740A (en) 2004-03-26
EP1246817A1 (en) 2002-10-09
SG152900A1 (en) 2009-06-29
NO323401B1 (no) 2007-04-23
MXPA02006590A (es) 2002-12-13
DK1464641T3 (da) 2008-08-18
KR100729536B1 (ko) 2007-06-18
US7223765B2 (en) 2007-05-29
PL355502A1 (en) 2004-05-04
NO20065681L (no) 2002-08-02
TR200402408T4 (tr) 2004-12-21
ES2302992T3 (es) 2008-08-01
EP1464641B1 (en) 2008-05-14
KR20070014234A (ko) 2007-01-31
TR200201690T2 (tr) 2002-11-21
ZA200205019B (en) 2003-09-22
NZ530137A (en) 2005-09-30
DE60038911D1 (de) 2008-06-26
DK1246817T3 (da) 2004-10-18
KR100792186B1 (ko) 2008-01-08
DE60011817D1 (de) 2004-07-29
JP2003519225A (ja) 2003-06-17
UA73756C2 (en) 2005-09-15
NO20023151D0 (no) 2002-06-28
US20060148815A1 (en) 2006-07-06
CA2395869C (en) 2006-07-25
ATE395333T1 (de) 2008-05-15
DE60011817T2 (de) 2005-07-14
KR20020063285A (ko) 2002-08-01
NO20023151L (no) 2002-08-02
ES2223628T3 (es) 2005-03-01
EA005013B1 (ru) 2004-10-28
CN1434819A (zh) 2003-08-06
US20030027832A1 (en) 2003-02-06
SK11072002A3 (sk) 2003-03-04
EA008627B1 (ru) 2007-06-29
ATE269857T1 (de) 2004-07-15
PT1464641E (pt) 2008-07-01
EP1464641A1 (en) 2004-10-06
US7074796B2 (en) 2006-07-11
CZ20022603A3 (cs) 2002-10-16
IL150366A (en) 2008-06-05
CA2395869A1 (en) 2001-07-12
EA200200729A1 (ru) 2002-12-26
AR029461A1 (es) 2003-07-02
WO2001049679A1 (en) 2001-07-12
PT1246817E (pt) 2004-11-30
IS6432A (is) 2002-06-19
IL186954A0 (en) 2009-02-11
AU2152701A (en) 2001-07-16

Similar Documents

Publication Publication Date Title
IL186954A0 (en) 4-phenyl-1-piperazinyl,-piperidinyl and tetrahydropyridyl derivatives
EG23817A (en) 4-Phenyl-pyridine derivatives
EP1223932A4 (en) COMPOUNDS AND METHODS
EP1146790A4 (en) COMPOUNDS AND METHODS
IL149374A0 (en) New use and novel n-azabicyclo-amide derivatives
HUP0201535A2 (en) 5-cyano-2-aminopyrimidine derivatives
GC0000183A (en) 3-Phenyl-pyridine derivatives
IL145739A0 (en) 13-methyl-erythromycin derivatives
GC0000338A (en) 5-Phenyl-pyrimidine derivatives
HK1044940A1 (zh) 異噁唑咪唑羧酰胺衍生物
HU0001396D0 (en) 3-amino-3-arylpropan-1-al derivatives and their use
GC0000191A (en) 4-Phenyl-pyrimidine derivatives
GB0023323D0 (en) Arylhydantoin derivatives and uses thereof
EP1194147A4 (en) DERIVATIVES OF ARYLTHIAZOLIDINEDIONE AND ARYLOXAZOLIDINEDIONE
GB0026485D0 (en) ›-Carboline derivatives
IL147636A0 (en) 3-amino-2-benzyl-1-phenyl-propane derivatives
GC0000256A (en) Ethanesulfonyl-piperidine derivatives
EP1229913A4 (en) SUBSTITUTED 1-BENZAZEPINE AND THEIR DERIVATIVES
PL352409A1 (en) Derivatives of 1-trifluorometyl-4-hydroxy-7-piperidinyl-aminomethylochromane
SI1246817T1 (en) 4-phenyl-1-piperazinyl, -piperidinyl and -tetrahydropyridyl derivatives
GB9916675D0 (en) Enigma-sip and enigma-cell
EG21695A (en) Pin-screw-ajusting and safe
GB0014089D0 (en) Methods and devices
IL149638A0 (en) S-allylmercaptoglutathione and uses thereof
SI1233964T1 (en) New use and novel n-azabicyclo-amide derivatives

Legal Events

Date Code Title Description
FF Patent granted
FF Patent granted